Madrigal Pharmaceuticals, Inc. Share Price
Equities
MDGL
US5588681057
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 523.69 USD | -3.00% |
|
+2.68% | -10.07% |
| 06/05 | Madrigal Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 06/05 | Madrigal Pharmaceuticals, Inc., Q1 2026 Earnings Call, May 06, 2026 |
| Capitalization | 1.21TCr 1.04TCr 949.95Cr 906.35Cr 1.66TCr 1,15800Cr 1.69TCr 11TCr 4.41TCr 55TCr 4.53TCr 4.43TCr 1,91600Cr | P/E ratio 2026 * |
-76.7x | P/E ratio 2027 * | 52.2x |
|---|---|---|---|---|---|
| Enterprise value | 1.15TCr 993.43Cr 908.31Cr 866.62Cr 1.59TCr 1,10800Cr 1.62TCr 11TCr 4.22TCr 53TCr 4.33TCr 4.24TCr 1,83200Cr | EV / Sales 2026 * |
7.72x | EV / Sales 2027 * | 4.97x |
| Free-Float |
94.3% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Madrigal Pharmaceuticals, Inc.
| 1 day | -3.00% | ||
| 1 week | +2.68% | ||
| Current month | +1.22% | ||
| 1 month | +0.99% | ||
| 3 months | +12.69% | ||
| 6 months | -1.04% | ||
| Current year | -10.07% |
| 1 week | 490.13 |  | 547.24 |
| 1 month | 490.13 | | 559 |
| Current year | 416.21 | | 598.79 |
| 1 year | 265 | | 615 |
| 3 years | 119.76 | | 615 |
| 5 years | 52.33 | | 615 |
| 10 years | 6.6 | | 615 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Sibold
CEO | Chief Executive Officer | 59 | 08/09/2023 |
Edward Chiang
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/2011 |
Mardi Dier
DFI | Director of Finance/CFO | 62 | 11/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Friedman
CHM | Chairman | 83 | 22/07/2016 |
Rebecca Taub
BRD | Director/Board Member | 73 | 01/07/2016 |
Ken Bate
BRD | Director/Board Member | 75 | 22/07/2016 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.00% | +2.68% | +79.46% | +80.40% | 1.21TCr | |
| -0.14% | +3.34% | +42.69% | +84.71% | 5.01TCr | |
| +0.12% | -3.44% | +67.99% | +49.40% | 4.58TCr | |
| -5.60% | +7.69% | +62.36% | +466.37% | 2.37TCr | |
| -2.65% | -4.86% | -3.02% | -17.01% | 2.26TCr | |
| +3.19% | +3.12% | +41.22% | -27.18% | 1.78TCr | |
| -1.66% | +2.59% | +30.04% | -41.59% | 1.61TCr | |
| -2.91% | -10.30% | +47.85% | +186.19% | 1.41TCr | |
| -7.00% | -6.69% | -26.94% | +821.86% | 1.31TCr | |
| +0.41% | -2.37% | +40.93% | - | 1.3TCr | |
| Average | -1.92% | -1.74% | +38.26% | +178.13% | 2.28TCr | |
| Weighted average by Cap. | -1.43% | -1.10% | +42.44% | +140.98% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 149.63Cr 128.76Cr 117.72Cr 112.32Cr 205.91Cr 14TCr 209.32Cr 1.41TCr 546.54Cr 6.81TCr 561.53Cr 549.5Cr 24TCr | 220.76Cr 189.96Cr 173.69Cr 165.71Cr 303.8Cr 21TCr 308.82Cr 2.08TCr 806.34Cr 10TCr 828.46Cr 810.71Cr 35TCr |
| Net income | -20Cr -17Cr -16Cr -15Cr -27Cr -1.89TCr -28Cr -186.23Cr -72Cr -898.55Cr -74Cr -72Cr -3.13TCr | 31Cr 27Cr 25Cr 23Cr 43Cr 3TCr 44Cr 295.08Cr 114.18Cr 1.42TCr 117.31Cr 114.8Cr 4.96TCr |
| Net Debt | -53Cr -46Cr -42Cr -40Cr -73Cr -5.08TCr -74Cr -499.54Cr -193.3Cr -2.41TCr -198.6Cr -194.35Cr -8.4TCr | -109.47Cr -94Cr -86Cr -82Cr -150.65Cr -11TCr -153.14Cr -1.03TCr -399.84Cr -4.99TCr -410.81Cr -402.01Cr -17TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/26/15 | 523.69 $ | -3.00% | 2,22,473 |
| 14/26/14 | 539.89 $ | +4.05% | 3,43,567 |
| 13/26/13 | 518.87 $ | +1.69% | 3,74,901 |
| 12/26/12 | 510.26 $ | +2.66% | 2,35,034 |
| 11/26/11 | 497.03 $ | -2.55% | 3,07,741 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MDGL Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition